1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

  • July 2018
  • 224 pages
  • ID: 5473810

Summary

Table of Contents

Search Inside

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market. However, shortage of vaccine supply due to genetic assortment of the viral strains is surging the need for updating vaccines each year by the manufacturers. This is a major factor restraining market growth.

Global Influenza Vaccines Market – Regional Analysis
• Geographically, North America is the largest market for influenza vaccines capturing over 48% market share in 2017.
• Asia is the second largest market for influenza vaccines.
• Europe is the third largest market for influenza vaccines, followed by Latin America.
• Australasia accounted for least share of the influenza vaccines market in 2017.

Global Influenza Vaccines Market – Country Wise Analysis
• On the basis of country, United States captures majority of the influenza vaccines market.
• Japan is the second largest market for influenza vaccines.
• China, Brazil and India are the third, fourth and fifth leading market for influenza vaccines respectively.
• Canada, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

Global Influenza Vaccines Market – Brands Analysis
• In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax.
• In May 2016, the cell-based Flucelvax quadrivalent shot was approved by the FDA.
• GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market.
• Fluad is the first and only adjuvanted seasonal influenza vaccine in the US for adults aged 65 and older.
• Flublok has captured least share of the influenza vaccines market.
• In October 2016, Protein Sciences received approval from the FDA for the quadrivalent version of Flublok vaccine.
• On August 28, 2017 - Sanofi announced that it has completed the acquisition of Protein Sciences.
• In February 2018, SK Chemicals Co. signed a US$ 155 Million deal to license cell culture technology to Sanofi Pasteur Inc. for development of a universal influenza vaccine.

This is the 4th edition report on influenza vaccines market by iGATE Research. The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024” provides a comprehensive assessment of the fast-evolving, high-growth influenza vaccines market landscape.

This 224 Page report with 139 Figures and 12 Tables has been analyzed from 5 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2024)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2024)
3. Global - Influenza Vaccines Brand Sales and Forecast to 2024
4. Global Influenza Vaccines Market - Major Deals
5. Global Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region
1. North America
2. Latin America
3. Europe
4. Asia
5. Australasia

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)
1. United States
2. Canada
3. Brazil
4. Mexico
5. Germany
6. France
7. Italy
8. Spain
9. United Kingdom
10. Netherlands
11. Ireland
12. Denmark
13. Luxembourg
14. Sweden
15. Australia
16. New Zealand
17. Japan
18. China
19. India
20. South Korea
21. Singapore
22. Hong Kong
23. Malaysia
24. Thailand
25. Indonesia

Influenza Vaccines Brand Sales and Forecast - 8 Brands Analyzed
1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok
8. Fluad

Companies Mentioned
GSK, Sanofi Pasteur, Novartis, bioCSL, Protein Sciences, Seqirus

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Cholera Vaccines Market Size, Share & Trends Analysis Report By Product, By Region And Segment Forecasts, 2018 - 2025

Cholera Vaccines Market Size, Share & Trends Analysis Report By Product, By Region And Segment Forecasts, 2018 - 2025

  • $ 5950
  • Industry report
  • August 2018
  • by Grand View Research

Cholera Vaccines Market Size, Share & Trends Analysis Report By Product (Dukoral, Shanchol, Vaxchora), By Region (North America, APAC, Europe, MEA, Latin America), And Segment Forecasts, 2018 - 2025The ...

Global Veterinary Vaccines Industry

Global Veterinary Vaccines Industry

  • $ 5600
  • Industry report
  • September 2018
  • by Global Industry Analysts

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine ...

Vaccines Market by Technology, Disease, Route, Patient, Type - Global Forecast to 2023

Vaccines Market: Global Forecast until 2023

  • $ 5649
  • Industry report
  • August 2018
  • by MarketsandMarkets

Global vaccines market projected to grow at a CAGR of 6.7%The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, ...

Cancer Vaccines: Analytical Tool $ 3950 September 2018


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on